Enric Xipell
Overview
Explore the profile of Enric Xipell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
340
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aldave G, Gonzalez-Huarriz M, Rubio A, Romero J, Ravi D, Minana B, et al.
Neuro Oncol
. 2018 Jan;
20(7):930-941.
PMID: 29373718
Background: Glioblastoma, the most aggressive primary brain tumor, is genetically heterogeneous. Alternative splicing (AS) plays a key role in numerous pathologies, including cancer. The objectives of our study were to...
2.
Marigil M, Martinez-Velez N, Dominguez P, Idoate M, Xipell E, Patino-Garcia A, et al.
PLoS One
. 2017 Jan;
12(1):e0170501.
PMID: 28107439
Objective: In this work we set to develop and to validate a new in vivo frameless orthotopic Diffuse Intrinsic Pontine Glioma (DIPG) model based in the implantation of a guide-screw...
3.
Acanda de la Rocha A, Lopez-Bertoni H, Guruceaga E, Gonzalez-Huarriz M, Martinez-Velez N, Xipell E, et al.
PLoS One
. 2016 Sep;
11(9):e0163155.
PMID: 27669421
Introduction: Glioblastoma is the most malignant brain tumor in adults and is associated with poor survival despite multimodal treatments. Glioma stem-like cells (GSCs) are cells functionally defined by their self-renewal...
4.
Vera B, Martinez-Velez N, Xipell E, de la Rocha A, Patino-Garcia A, Castresana J, et al.
PLoS One
. 2016 Jun;
11(6):e0157619.
PMID: 27280773
[This corrects the article DOI: 10.1371/journal.pone.0147211.].
5.
Xipell E, Gonzalez-Huarriz M, Martinez de Irujo J, Garcia-Garzon A, Lang F, Jiang H, et al.
Oncotarget
. 2016 Apr;
7(21):30626-41.
PMID: 27121320
Glioblastoma is the most frequent malignant brain tumor. Even with aggressive treatment, prognosis for patients is poor. One characteristic of glioblastoma cells is its intrinsic resistance to apoptosis. Therefore, drugs...
6.
Xipell E, Aragon T, Martinez-Velez N, Vera B, Idoate M, Martinez-Irujo J, et al.
Neuro Oncol
. 2016 Mar;
18(8):1109-19.
PMID: 26951384
Background: Endoplasmic reticulum (ER) stress results from protein misfolding imbalance and has been postulated as a therapeutic strategy. ER stress activates the unfolded protein response which leads to a complex...
7.
Vera B, Martinez-Velez N, Xipell E, de la Rocha A, Patino-Garcia A, Saez-Castresana J, et al.
PLoS One
. 2016 Jan;
11(1):e0147211.
PMID: 26808201
Despite the recent advances in the development of antitumor therapies, the prognosis for patients with malignant gliomas remains dismal. Therapy with tumor-selective viruses is emerging as a treatment option for...
8.
Martinez-Velez N, Xipell E, Vera B, de la Rocha A, Zalacain M, Marrodan L, et al.
Clin Cancer Res
. 2015 Nov;
22(9):2217-25.
PMID: 26603261
Purpose: Osteosarcoma is the most common malignant bone tumor in children and adolescents. Despite aggressive chemotherapy, more than 30% of patients do not respond and develop bone or lung metastasis....
9.
Martinez-Velez N, Xipell E, Jauregui P, Zalacain M, Marrodan L, Zandueta C, et al.
J Bone Miner Res
. 2014 Apr;
29(10):2287-96.
PMID: 24737304
Osteosarcoma is the most common malignant bone tumor in children and adolescents. The presence of metastases and the lack of response to conventional treatment are the major adverse prognostic factors....
10.
Manterola L, Guruceaga E, Gallego Perez-Larraya J, Gonzalez-Huarriz M, Jauregui P, Tejada S, et al.
Neuro Oncol
. 2014 Jan;
16(4):520-7.
PMID: 24435880
Background: Glioblastoma multiforme (GBM) is the most frequent malignant brain tumor in adults, and its prognosis remains dismal despite intensive research and therapeutic advances. Diagnostic biomarkers would be clinically meaningful...